PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529922
PUBLISHER: Coherent Market Insights | PRODUCT CODE: 1529922
Global clinical laboratory services market is estimated to be valued at USD 280.10 Bn in 2024 and is expected to reach USD 435.11 Bn by 2031, exhibiting a compound annual growth rate (CAGR) of 6.5% from 2024 to 2031.
Report Coverage | Report Details | ||
---|---|---|---|
Base Year: | 2023 | Market Size in 2024: | US$ 280.10 Bn |
Historical Data for: | 2019 to 2023 | Forecast Period: | 2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: | 6.50% | 2031 Value Projection: | US$ 435.11 Bn |
Global clinical laboratory services market is witnessing growth due to rising prevalence of chronic diseases such as cancer, diabetes, and cardiovascular diseases. Growing geriatric population who are prone to developing such health conditions has boosted demand for diagnostic tests across the world. Furthermore, technological advancements in various diagnostic modalities like molecular diagnostics, clinical chemistry testing, medical microbiology, and hematology have enabled accurate and efficient testing procedures. Rapid automation in clinical laboratories and point-of-care testing have expanded access to diagnostics. Various governments support laboratory infrastructure development through public-private partnerships. However, high cost of diagnostic equipment and lack of skilled professionals in developing nations can hamper the market growth.
Global clinical laboratory services market growth is driven by rising geriatric population globally that requires frequent medical tests for various age-related health issues. Furthermore, increasing prevalence of lifestyle diseases such as cancer, diabetes, cardiovascular diseases have significantly boosted demand for clinical pathology services. High cost of diagnostic equipment, reagents, and maintenance can hamper its widespread adoption, especially in price-sensitive developing markets. Moreover, lack of requisite skilled professionals can pose challenge for clinical laboratories in low and middle-income countries. Growing adoption of automation, robotics, and point-of-care testing devices can offer new market growth opportunities. Technological advancements enable more accurate and faster diagnosis, thus, driving the market growth.
Detailed Segmentation-